October 8, 2021
October 8, 2021 – TavneosTM (avacopan – ChemoCentryx) is now U.S. FDA approved for use in adults as
an adjunct to standard therapy (including glucocorticoids)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
October 5, 2021
October 5, 2021 – Tecartus® (brexucabtagene autoleucel) has received a new indication to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults
October 5, 2021
October 5, 2021 – Medtronic is expanding a 2019 recall of its MiniMedTM 600 Series Insulin Pumps to include any MiniMed 600 series pump that has a clear retainer ring
October 1, 2021
October 1, 2021 – Bayer has recalled all unexpired Lotrimin® AF and Tinactin® spray products distributed between September 2018 to September 2021, with lot number beginning
September 29, 2021
September 29, 2021 – The U.S. FDA has approved LivmarliTM (maralixibat) oral solution to treat cholestatic pruritus in patients who are at least one year old and have been
September 28, 2021
September 28, 2021
September 28, 2021 – Qulipta® (atogepant) from AbbVie has received FDA approval for the preventive treatment of episodic migraine in adults.
September 28, 2021
September 28, 2021 – Starting January 1, 2022, Eli Lilly will reduce the cost of all its non-branded insulin products. This includes the company's Insulin Lispro Injection